Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death

Journal of Immunology

Volumn 188, Issue 3, 2012, Pages 1057-1063

  Lovo, Elena ^a   Zhang, Manling ^a,b   Wang, Lihui ^a   Ashton Rickardt, Philip G ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR 6; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; ENZYME DEFICIENCY; ENZYME INHIBITION; EX VIVO STUDY; FLOW CYTOMETRY; KISS OF DEATH; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; GRANZYMES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SERPINS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84863042239     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102667     Document Type: Article

References (33)

1. Ashton-Rickardt, P. G. 2010. Serine protease inhibitors and cytotoxic T lymphocytes. Immunol. Rev. 235: 147-158.
2. Opferman, J. T., B. T. Ober, and P. G. Ashton-Rickardt. 1999. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283: 1745-1748.
3. Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
4. Lau, L. L., B. D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell memory without antigen. Nature 369: 648-652. (Pubitemid 24201043)
5. Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220. (Pubitemid 35245963)
6. Zammit, D. J., L. S. Cauley, Q. M. Pham, and L. Lefrançois. 2005. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 22: 561-570. (Pubitemid 40719192)
7. Belz, G. T., K. Shortman, M. J. Bevan, and W. R. Heath. 2005. CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175: 196-200. (Pubitemid 40884318)
8. Heath, W. R., G. T. Belz, G. M. Behrens, C. M. Smith, S. P. Forehan, I. A. Parish, G. M. Davey, N. S. Wilson, F. R. Carbone, and J. A. Villadangos. 2004. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol. Rev. 199: 9-26. (Pubitemid 38736761)
9. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76: 977-987. (Pubitemid 24106379)
10. Hermans, I. F., D. S. Ritchie, J. Yang, J. M. Roberts, and F. Ronchese. 2000. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J. Immunol. 164: 3095-3101. (Pubitemid 30148970)
11. Yang, J., S. P. Huck, R. S. McHugh, I. F. Hermans, and F. Ronchese. 2006. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA 103: 147-152. (Pubitemid 43076119)
12. Curtsinger, J. M., C. M. Johnson, and M. F. Mescher. 2003. CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J. Immunol. 171: 5165-5171. (Pubitemid 37432800)
13. Jusforgues-Saklani, H., M. Uhl, N. Blachère, F. Lemaître, O. Lantz, P. Bousso, D. Braun, J. J. Moon, and M. L. Albert. 2008. Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming. J. Immunol. 181: 3067-3076.
14. Wakim, L. M., J. Waithman, N. van Rooijen, W. R. Heath, and F. R. Carbone. 2008. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319: 198-202.
15. Wong, P., and E. G. Pamer. 2003. Feedback regulation of pathogen-specific T cell priming. Immunity 18: 499-511. (Pubitemid 36513632)
16. Sun, J., L. Ooms, C. H. Bird, V. R. Sutton, J. A. Trapani, and P. I. Bird. 1997. A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9). J. Biol. Chem. 272: 15434-15441. (Pubitemid 27255569)
17. Medema, J. P., D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E. M. Toes, M. Toebes, T. N. M. Schumacher, et al. 2001. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194: 657-667. (Pubitemid 32844775)
18. Andrew, K. A., H. M. Simkins, S. Witzel, R. Perret, J. Hudson, I. F. Hermans, D. S. Ritchie, J. Yang, and F. Ronchese. 2008. Dendritic cells treated with lipopolysaccharide up-regulate serine protease inhibitor 6 and remain sensitive to killing by cytotoxic T lymphocytes in vivo. J. Immunol. 181: 8356-8362.
19. Zhang, M., S. M. Park, Y. Wang, R. Shah, N. Liu, A. E. Murmann, C. R. Wang, M. E. Peter, and P. G. Ashton-Rickardt. 2006. Serine protease inhibitor 6 protects cytotoxic T cells from self-inflicted injury by ensuring the integrity of cytotoxic granules. Immunity 24: 451-461.
20. Zhang, M., S. Byrne, N. Liu, Y. Wang, A. Oxenius, and P. G. Ashton-Rickardt. 2007. Differential survival of cytotoxic T cells and memory cell precursors. J. Immunol. 178: 3483-3491. (Pubitemid 46417613)
21. Lutz, M. B., N. Kukutsch, A. L. J. Ogilvie, S. Rössner, F. Koch, N. Romani, and G. Schuler. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223: 77-92. (Pubitemid 29096240)
22. Matzinger, P. 1991. The JAM test. A simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145: 185-192.
23. McCausland, M. M., and S. Crotty. 2008. Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. J. Virol. Methods 147: 167-176. (Pubitemid 350250859)
24. Kataoka, T., N. Shinohara, H. Takayama, K. Takaku, S. Kondo, S. Yonehara, and K. Nagai. 1996. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. J. Immunol. 156: 3678-3686. (Pubitemid 26139940)
25. Yu, Y., A. Arora, W. Min, C. M. Roifman, and E. Grunebaum. 2009. EdU incorporation is an alternative non-radioactive assay to [(3)H]thymidine uptake for in vitro measurement of mice T-cell proliferations. J. Immunol. Methods 350: 29-35.
26. Wolint, P., M. R. Betts, R. A. Koup, and A. Oxenius. 2004. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med. 199: 925-936. (Pubitemid 38481084)
27. Villadangos, J. A., and P. Schnorrer. 2007. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7: 543-555. (Pubitemid 46987783)
28. Ansari, A. W., J. N. Temblay, S. H. Alyahya, and P. G. Ashton-Rickardt. 2010. Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage. J. Immunol. 185: 877-883.
29. El Haddad, N., D. Heathcote, R. Moore, S. Yang, J. Azzi, B. Mfarrej, M. Atkinson, M. H. Sayegh, J. S. Lee, P. G. Ashton-Rickardt, and R. Abdi. 2011. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response. Blood 117: 1176-1183.
30. Sprecher, C. A., K. A. Morgenstern, S. Mathewes, J. R. Dahlen, S. K. Schrader, D. C. Foster, and W. Kisiel. 1995. Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors. J. Biol. Chem. 270: 29854-29861. (Pubitemid 26001658)
31. Sun, J., C. H. Bird, V. Sutton, L. McDonald, P. B. Coughlin, T. A. De Jong, J. A. Trapani, and P. I. Bird. 1996. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J. Biol. Chem. 271: 27802-27809. (Pubitemid 26367355)
32. Annand, R. R., J. R. Dahlen, C. A. Sprecher, P. De Dreu, D. C. Foster, J. A. Mankovich, R. V. Talanian, W. Kisiel, and D. A. Giegel. 1999. Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem. J. 342: 655-665. (Pubitemid 29452651)
33. Cao, X., S. F. Cai, T. A. Fehniger, J. Song, L. I. Collins, D. R. Piwnica-Worms, and T. J. Ley. 2007. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 27: 635-646. (Pubitemid 47628832)